BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mi J, He Y, Yang J, Zhou Y, Zhu G, Wu A, Liu W, Sang Z. Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease. Bioorg Med Chem Lett 2022;:128574. [PMID: 35065231 DOI: 10.1016/j.bmcl.2022.128574] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Goyal A, Verma A, Dubey N, Raghav J, Agrawal A. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease. J Food Biochem 2022;46:e14415. [PMID: 36106706 DOI: 10.1111/jfbc.14415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Masi M, Attanzio A, Racchi M, Wolozin B, Borella S, Biundo F, Buoso E. Proteostasis Deregulation in Neurodegeneration and Its Link with Stress Granules: Focus on the Scaffold and Ribosomal Protein RACK1. Cells 2022;11:2590. [PMID: 36010666 DOI: 10.3390/cells11162590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang H, Wang Y, Wang Y, Li X, Wang S, Wang Z. Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease. Eur J Med Chem 2022;240:114606. [PMID: 35858523 DOI: 10.1016/j.ejmech.2022.114606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Yao Z, Wu S, Zhang H, Feng X, Wang Z, Lin M. Chiral Determination of Naringenin by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry and Application in Citrus Peel and Pulp. Front Nutr 2022;9:906859. [DOI: 10.3389/fnut.2022.906859] [Reference Citation Analysis]